Insight Molecular Diagnostics Investor Relations Material
Latest events
Status Update
Insight Molecular Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Insight Molecular Diagnostics Inc
Access all reports
OncoCyte Corporation develops and markets molecular diagnostics for use in oncology and transplantation. The company focuses on liquid biopsy technologies and gene expression testing to support clinical decision-making in patient care. Its services are aimed at healthcare providers and research institutions. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Key slides for Insight Molecular Diagnostics Inc
Investor Presentation
Insight Molecular Diagnostics Inc
Investor Presentation
Insight Molecular Diagnostics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
IMDX
Country
🇺🇸 United States